Tag Archives: TNF

October, 2017

November, 2016

  • 23 November

    AbbVie Terminates Development Program with Halozyme

    SAN DIEGO, Nov. 21, 2016 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that AbbVie has discontinued a development program using the Halozyme ENHANZE™ platform technology and the tumor necrosis factor alpha (TNF-alpha) target following completion of a phase 1 study in which the target results were not achieved. …

July, 2016

March, 2016